Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts

Inclusion Criteria:

* Healthy subject.
* Sex: male or female.
* Age: more than 4 years old.
* Subject presenting at least 1 new common wart on hand or a plantar wart (wart present since less than 6 months) of a size less than 0.8cm.
* Subject, including minors aged more than 16 years, having given freely and expressly his/her informed consent.
* Minor whose legal guardians have given their free and express informed consent.
* Subject who is able to comply with the study requirements, as defined in the present rotocol, at the Investigator's appreciation.
* Subject or child's legal guardians being affiliated to a health social security system.
* Female subject of childbearing potential should use a medically accepted contraceptive regimen (at the Investigator's discretion) since at least 12 weeks before the beginning of the study, during all the study.

Exclusion Criteria:

* Pregnant, parturient, or nursing woman or planning a pregnancy during the study.
* Subject who had been deprived of their freedom by administrative or legal decision.
* Subject in a social or sanitary establishment.
* Major subject who is under guardianship or who is not able to express his consent.
* Subject suspected to be non-compliant according to the Investigator's judgment.
* Subject suffering from a severe or progressive disease or any other pathology that may interfere with the evaluation of the study results.
* Subject with a cutaneous disease other than common and plantar warts, on the studied zone.
* Subject with a known allergy to one of the component of the products or to the comparator.
* Subject who has diabetes.
* Subject having problems with blood circulation, or having a blood clotting condition.
* Subject with immune deficiency or autoimmune disease.
* Subject presenting more than 10 warts on the body.
* Subject presenting bleeding warts.
* Subject presenting birthmarks, moles, warts with hairs growing from them, or any other spots on the treated and surrounding area.
* Subject having a sensitive skin, inflamed, infected, irritated, red, damaged, cut, grazed, diseased or itchy on the treated zone.
* Subject presenting genital warts, flat warts, filiform warts, periungual warts or warts larger than 0.8cm.
* Subject presenting 2 or more warts adjacent to each other.
* Subject undergoing a topical treatment on the test area or a systemic treatment:
* anti-inflammatory medication during the previous 2 weeks and during the study,
* immunosuppressors and/or corticoids during the 4 previous weeks and during the study,
* retinoids during the 6 previous months and during the study,
* any medication stabilized for less than one month.
* Subject who received a treatment of any type on the selected wart during the previous 6 months.
* Intensive exposure to sunlight or UV-rays on the studied zone within the previous month and/or foreseen during the study.
* Subject planning to change her/his life habits during the study.